Show items per page
Elements: 26
Page 1 on 2
 TitleAuthors / EditorsDate
add to browser selection
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study Cain, Lauren E; Logan, Roger; Robins, James M; Sterne, Jonathan A C; ... Wyler, Claire-Anne 2011
add to browser selection
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; Yerly Ferrillo, Sabine; ... Günthard, Huldrych F 2011
add to browser selection
Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study Drescher, Sara M; von Wyl, Viktor; Yang, Wan-Lin; Böni, Jürg; ... Calmy, Alexandra 2014
add to browser selection
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey Yerly Ferrillo, Sabine; von Wyl, Viktor; Ledergerber, Bruno; Boni, Jurg; ... Perrin, Luc 2007
add to browser selection
The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research Steinemann, Nina; Kuhle, Jens; Calabrese, Pasquale; Kesselring, Jürg; ... von Wyl, Viktor 2018
add to browser selection
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients Beerenwinkel, Niko; Montazeri, Hesam; Schuhmacher, Heike; Knupfer, Patrick; ... Calmy, Alexandra 2013
add to browser selection
The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection Yerly Ferrillo, Sabine; Junier, Thomas; Gayet-Ageron, Angèle; Boffi El Amari, Emmanuelle Jane; ... Kaiser, Laurent 2009
add to browser selection
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals Ray, Maile; Logan, Roger; Sterne, Jonathan A C; Hernández-Díaz, Sonia; ... Hernán, Miguel A 2010
add to browser selection
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals: the Swiss HIV Cohort Study Fehr, Jan; Glass, Tracy R; Louvel, Séverine; Hamy, François; ... Klimkait, Thomas 2011
add to browser selection
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; Hirschel, Bernard; ... Bucher, H. C. 2007
add to browser selection
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection Metzner, Karin J; Scherrer, Alexandra U; Preiswerk, Benjamin; Joos, Beda; ... Günthard, Huldrych F 2013
add to browser selection
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland Kouyos, R. D.; von Wyl, Viktor; Yerly Ferrillo, Sabine; Boni, Jurg; ... Gunthard, Huldrych 2010
add to browser selection
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients Scherrer, Alexandra U; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2012
add to browser selection
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland von Wyl, Viktor; Yerly Ferrillo, Sabine; Burgisser, Philippe; Klimkait, Thomas; ... Swiss, H. I. V. Cohort Stud 2009
add to browser selection
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients Metzner, Karin J; Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2014
add to browser selection
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations von Wyl, Viktor; Yerly Ferrillo, Sabine; Böni, Jürg; Shah, Cyril; ... Günthard, Huldrych F 2012
add to browser selection
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures Scherrer, A. U.; von Wyl, Viktor; Fux, C. A.; Opravil, Milos; ... Gunthard, Huldrych 2010
add to browser selection
Governance Mechanisms for Access and Use of Data in Public Health Crises: Call for Action Thouvenin, Florent; de Werra, Jacques; Benhamou, Yaniv; Bernstein, Abraham; ... von Wyl, Viktor 2022
add to browser selection
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir von Wyl, Viktor; Yerly Ferrillo, Sabine; Böni, Jürg; Bürgisser, Philippe; ... Günthard, Huldrych F. 2008
add to browser selection
Estimating the basic reproductive number from viral sequence data Stadler, Tanja; Kouyos, Roger; von Wyl, Viktor; Yerly Ferrillo, Sabine; ... Bonhoeffer, Sebastian 2012
<< previous | 1 | 2 |